Keros Therapeutics, Inc.KROSNASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$91.90M
↑ 257% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
$-58.56M
Historical baseline
PeriodValueYoY Change
TTM$91.90M+149.1%
2024$-187.05M-22.3%
2023$-152.99M-46.2%
2022$-104.68M-84.5%
2021$-56.73M-24.6%
2020$-45.53M-269.1%
2019$-12.34M-1044.3%
2018$-1.08M-